J. E. Oltra, J. M. Cuerva et al.
7.3 Hz, 2H); 13C NMR (100 MHz, CDCl3; DEPT): d=146.3 (C), 133.8
(CH), 128.0 (CH), 126.7 (CH), 125.6 (CH), 119.4 (CH2), 47.3 (CH2), 21.7
(CH), 1.6 (CH2), 0.6 ppm (CH2) (one carbon signal was not observed);
IR (film) nmax =3472, 3007 cmÀ1; HRMS EI: m/z calcd for C13H15O
[MÀH]+: 187.1123; found: 187.1122.
8.4 Hz, 2H). This compound is quite unstable and we could obtain nei-
ther 13C NMR nor HRMS data.
General procedure for Barbier-type cyclizations promoted by [TiClCp2]
(GP6): Strictly deoxygenated THF (20 mL) was added to a mixture of
[TiCl2Cp2] (2.2 mmol) and Mn dust (8 mmol) under an Ar atmosphere
and the suspension was stirred at room temperature until it turned lime
green (after about 15 min). Then, a solution of substrate 58 (1 mmol) in
THF (1 mL) was slowly added over a period of 15 min and the mixture
was stirred for 6 h. The reaction was quenched with brine and extracted
with EtOAc. The organic layer was washed with brine and dried (anhyd
Na2SO4), and the solvent was removed. Product 62 (73%) was purified
by flash chromatography on silica gel (hexane/EtOAc 8:2) and character-
ized by spectroscopic techniques.
Preparation of compound 50 (3:2 mixture of diastereomers): Following
GP1 and GP3, compound 50 was obtained as a colorless oil; 1H NMR
(400 MHz, CDCl3): d=6.03–5.86 (m, 2H), 5.21–5.10 (m, 4H), 4.68–4.59
(m, 2H), 4.54 (d, J=2.6 Hz, 1H)*, 4.39 (d, J=2.6 Hz, 1H), 4.28–4.25 (m,
4H), 3.98–3.62 (m, 3H), 2.51–2.25 (m, 4H), 1.60 (brs, 2H; both OH),
1.59 (s, 3H)*, 1.58 (s, 3H), 1.55 (s, 3H)*, 1.50 (s, 3H), 1.45 (s, 3H), 1.41
(s, 3H)*, 1.39 (s, 3H)*, 1.38 ppm (s, 3H); 13C NMR (100 MHz, CDCl3;
DEPT): d=136.2 (CH)*, 135.6 (CH), 117.9 (CH2), 116.7 (CH2)*, 109.4
(C)*, 109.2 (C), 108.7 (C), 108.5 (C)*, 104.8 (C), 104.4 (C)*, 75.4 (CH),
72.8 (CH)*, 72.3 (CH), 71.1 (CH), 70.8 (CH)*, 70.6 (C), 70.2 (CH)*, 61.5
(CH2), 61.2 (CH2)*, 35.9 (CH2), 35.7 (CH2)*, 26.6 (CH3), 26.5 (CH3)*,
26.0 (CH3), 26.0 (CH3)*, 25.9 (CH3)*, 25.8 (CH3), 24.2 (CH3), 24.0 ppm
(CH3)* (one carbon signal was not observed) (signals with asterisk corre-
spond to the minor diastereomer); HRMS FAB: m/z calcd for
C15H24O6Na [M+Na]+: 323.3386; found: 323.3382.
General procedure for Barbier-type cyclizations catalyzed by [TiClCp2]
(GP7): Strictly deoxygenated THF (20 mL) was added to a mixture of
[TiCl2Cp2] (0.2 mmol) and Mn dust (8 mmol) under an Ar atmosphere
and the suspension was stirred at room temperature until it turned lime
green (after about 15 min). Then, 2,4,6-collidine (7 mmol), and Me3SiCl
(4 mmol) were added. Finally, a solution of the corresponding substrate
(54, 55, and 58–61; 1 mmol) in THF (1 mL) was slowly added over a
period of 15 min and the mixture was stirred for 6 h. The reaction was
quenched with brine and extracted with EtOAc. The organic layer was
washed with brine and dried (anhyd Na2SO4), and the solvent was re-
moved. Products 56, and 62–67 were purified by flash chromatography
on silica gel (hexane/EtOAc) and characterized by spectroscopic tech-
niques. Yields obtained are reported in Table 5 and the body text.
General procedure for the synthesis of allylic bromides 54, 55, and 58–61
(GP5): PBr3 (2 mmol) was added to a solution of the corresponding allyl-
ic alcohol (1 mmol; for the preparation of these allylic alcohols see Sup-
porting Information) in Et2O (20 mL) at 08C. The mixture was stirred at
room temperature for 4 h. Then, the mixture was diluted with Et2O,
washed with brine, and dried (anhyd Na2SO4) and the solvent was re-
moved. The residue was used in the next step without further purifica-
tion.
Preparation of compound 56: Following GP7, compound 56 was ob-
tained as a colorless oil; 1H NMR (400 MHz, CDCl3): d=5.91 (ddd, J=
17.1, 10.2, 7.2 Hz, 1H), 5.21 (dd, J=10.2, 0.9 Hz, 1H), 5.15 (dd, J=17.1,
0.9 Hz, 1H), 3.78 (s, 3H), 3.73 (s, 3H), 2.40–1.98 (m, 5H), 1.73 (dt, J=
14.1, 3.3 Hz, 1H), 1.54 (td, J=14.1, 4.5 Hz, 1H), 1.20 ppm (s, 3H); NOE-
diff. experiment: proton irradiated, (NOEs observed): H-7, (H2–8, H3–9);
13C NMR (75 MHz, CDCl3; DEPT): d=172.7 (C), 171.8 (C), 137.9 (CH),
117.6 (CH2), 69.4 (C), 54.9 (C), 52.9 (CH3), 52.7 (CH3), 46.7 (CH), 36.3
(CH2), 31.8 (CH2), 29.4 (CH3), 26.6 ppm (CH2); HRMS ES: m/z calcd for
C13H20O5Na [M+Na]+: 279.1202; found: 279.1192; the relative configura-
tion of 56 was established on the basis of NOE-diff. experiments per-
formed on its acetyl derivative 57.
Preparation of allylic bromide 54: Following GP5, compound 54 was ob-
tained as a colorless oil (48 mg, 70%); 1H NMR (400 MHz, CDCl3): d=
5.75–5.70 (m, 1H), 5.39–5.33 (m, 1H), 3.99 (d, J=8.4 Hz, 2H), 3.70 (s,
6H), 2.65 (d, J=8 Hz, 2H), 2.44 (t, J=7.3 Hz, 2H), 2.12 (t, J=8.4 Hz,
2H), 2.11 ppm (s, 3H). This compound is quite unstable and we could
obtain neither 13C NMR nor HRMS data.
Preparation of allylic bromide 55: Following GP5, compound 55 was ob-
1
tained as a colorless oil (226 mg, 75%); H NMR (500 MHz, CDCl3): d=
5.70 (dt, J=15.0, 5.7 Hz, 1H), 5.52 (dt, J=15.0, 5.7 Hz, 1H), 3.91 (d, J=
6.6 Hz, 2H), 3.70 (s, 6H), 2.62 (d, J=7.2 Hz, 2H), 2.44 (t, J=8.0 Hz,
2H), 2.12 (s, 3H), 2.11 ppm (t, J=7.5 Hz, 2H). This compound is quite
unstable and we could obtain neither 13C NMR nor HRMS data.
Preparation of compound 57: Treatment of 56 with acetyl chloride in the
presence of 4-dimethylaminopyridine (DMAP) generated compound 57
as a colorless oil; 1H NMR (400 MHz, CDCl3): d=5.83–5.68 (m, 1H),
5.22–5.10 (m, 2H), 3.77 (s, 3H), 3.70 (s, 3H), 3.02 (dt, J=14.8, 3.2 Hz,
1H), 2.29 (s, 3H), 2.26–2.19 (m, 2H), 2.15 (dt, J=11.2, 3.2 Hz, 1H), 2.03–
1.93 (m, 1H), 1.86–1.77 (m, 1H), 1.54 (s, 3H), 1.41 ppm (td, J=14.8,
3.6 Hz, 1H); NOE-diff. experiment: proton irradiated, (NOEs observed):
H-6b, (H3–9, H-2, H-6a), H3–9, (H-2, H-6a, H-6b) , H-6a, (H-6b, H3–9);
13C NMR (125 MHz, CDCl3; DEPT): d=172.3 (C), 171.6 (C), 167.3 (C),
137.0 (CH), 118.1 (CH2), 83.2 (C), 54.4 (C), 52.9 (CH3), 52.9 (CH3), 49.2
(CH), 32.7 (CH2), 31.3 (CH2), 26.7 (CH2), 25.6 (CH3), 24.2 ppm (CH3).
Preparation of allylic bromide 58: Following GP5, compound 58 was ob-
1
tained as a colorless oil (126 mg, 82%); H NMR (400 MHz, CDCl3): d=
8.01 (brd, J=7.5 Hz, 4H) 7.72 (brt, J=7.5 Hz, 2H), 7.60 (t, J=7.5 Hz,
4H), 5.86 (m, 1H), 5.73 (m, 1H), 3.83 (d, J=8.3 Hz, 2H), 2.98 (dd, J=
6.4, 1.6 Hz, 2H), 2.92 (t, J=7.6 Hz, 2H), 2.50 (brt, J=7.6 Hz, 2H),
2.14 ppm (s, 3H); 13C NMR (100 MHz, CDCl3; DEPT): d=206.1 (C),
136.7 (C), 135.1 (CH), 131.6 (CH), 129.4 (CH), 129.1 (CH), 126.4 (CH),
89.4 (C), 38.0 (CH2), 30.2 (CH3), 28.1 (CH2), 25.8 (CH2), 23.8 ppm (CH2).
Preparation of disulfone 62: Following GP6 and GP7, compound 62 was
obtained as a colorless oil; 1H NMR (500 MHz, CDCl3): d=8.10 (d, J=
7.9 Hz, 2H), 8.00 (d, J=7.9 Hz, 2H), 7.69 (m, 2H), 7.58 (m, 4H), 5.80
(m, 1H), 5.19 (d, J=10.3 Hz, 1H), 5.15 (d, J=17.4 Hz, 1H), 2.92 (m,
1H), 2.68 (dt, J=14.1, 5.1 Hz, 1H), 2.62 (t, J=12.8 Hz, 1H), 2.31 (dt, J=
13.8, 4.5 Hz, 1H), 2.20 (dd, J=14.8, 2.1 Hz, 1H), 2.08 (dt, J=14.4,
3.2 Hz, 1H), 1.72 (ddd, J=8.8, 5, 2 Hz, 1H), 1.24 ppm (s, 3H); 13C NMR
(125 MHz, CDCl3; DEPT): d=139.6 (CH), 139.2 (C), 138.7 (C), 137.1
(CH), 136.9 (CH), 134.1 (CH), 133.7 (CH), 131.1 (CH), 131.0 (CH),
120.8 (CH2), 90.3 (C), 71.2 (C), 48.0 (CH), 37.6 (CH2), 31.3 (CH3), 29.8
(CH2), 24.9 ppm (CH2).
Preparation of allylic bromide 59: Following GP5, compound 59 was ob-
tained as a colorless oil (476 mg, 80%); H NMR (500 MHz, CDCl3): d=
1
7.61 (d, J=8.3, 2H) 7.24 (d, J=8 Hz, 2H), 5.78 (m, 1 H-cis), 5.32 (m,
1H), 3.89 (d, J=8.4 Hz, 2H), 3.84 (d, J=7 Hz, 2H), 3.25 (t, J=7 Hz,
2H), 2.76 (t, J=7.2 Hz, 2H), 2.36 (s, 3H), 2.07 ppm (s, 3H); 13C NMR
(100 MHz, CDCl3; DEPT): d=206.8 (C), 143.7 (C), 136.2 (C), 129.9
(CH), 129.5 (CH), 129.3 (CH), 127.3 (CH), 45.3 (CH2), 43.6 (CH2), 42.9
(CH2), 30.3 (CH3), 25.5 (CH2), 21.6 ppm (CH3).
Preparation of allylic bromide 60: Following GP5, compound 60 was ob-
tained as a colorless oil (72%); 1H NMR (500 MHz, CDCl3): d=9.75 (s,
1H), 5.76–5.69 (m, 1H), 5.57–5.49 (m, 1H), 3.91 (d, J=6.6 Hz, 2H), 3.76
(s, 6H), 2.66 (d, J=7.2 Hz, 2H), 2.47 (t, J=7.4 Hz, 2H), 2.19 ppm (t, J=
7.3 Hz, 2H). This compound is quite unstable and we could obtain nei-
ther 13C NMR nor HRMS data.
Preparation of piperidine 63: Following GP7, compound 63 was obtained
as a colorless oil; 1H NMR (500 MHz, CDCl3): d=7.64 (d, J=8.2 Hz,
2H), 7.32 (d, J=8.2 Hz, 2H), 5.83 (m, 1H), 5.20 (m, 2H), 3.28 (dd, J=
11.7, 3.4 Hz, 1H), 3.17 (m, 1H), 3.03 (m, 1H), 2.90 (dd, J=11.5, 6.7 Hz,
1H), 2.43 (s, 3H), 2.26 (m, 1H), 1.79 (m, 1H), 1.63 (m, 1H), 1.08 ppm (s,
3H); 13C NMR (125 MHz, CDCl3; DEPT): d=143.6 (C), 135.3 (CH),
133.5 (C), 129.8 (CH) ,127.7 (CH), 118.8 (CH2), 69.6 (CH), 50.9 (CH),
47.3 (CH2), 43.2 (CH2), 36.8 (CH2), 29.8 (CH2), 25.1 (CH3), 21.6 ppm
Preparation of allylic bromide 61: Following GP5, compound 61 was ob-
tained as a colorless oil (65%); 1H NMR (400 MHz, CDCl3): d=9.76 (s,
1H), 5.79–5.72 (m, 1H), 5.42–5.37 (m, 1H), 3.96 (d, J=8.4 Hz, 2H), 3.73
(s, 6H), 2.74 (d, J=6.8 Hz, 2H), 2.51 (t, J=7.6 Hz, 2H), 2.21 (t, J=
2786
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 2774 – 2791